DONALD BERGSTROM, M.D., PH.D.
Dr. Bergstrom has served as Executive Vice President, Head of Research and Development at Relay Therapeutics, Inc., a clinical-stage precision medicine company deploying cutting-edge experimental and computational tools since 2018. He also currently serves as a board observer on the Cellectis S.A. Board of Directors. From 2014 to 2018, Dr. Bergstrom was Senior Vice President, Chief Medical Officer at Mersana Therapeutics, Inc., a clinical-stage biopharmaceutical company discovering and developing novel antibody-drug-conjugates for the treatment of cancer. Prior to Mersana, Dr. Bergstrom was Global Head of Translational and Experimental medicine at Sanofi Oncology and held roles of increasing responsibility in oncology translational medicine and early clinical development at Merck Research Laboratories.
Dr. Bergstrom holds an M.D. and a Ph.D. from the University of Washington, Seattle and a B.A. from the Johns Hopkins University.